Category: News

Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics

MAY 26, 2021 – SINGAPORE & SAN CARLOS, Calif.–Engine Biosciences (“Engine”) today announced the successful completion of an oversubscribed $43 million Series A funding

Hummingbird Bioscience Raises US$125 Million in Series C Financing

SINGAPORE, May 17, 2021 – Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes,

Cityneon Raises S$235 Million; Well Positioned For Next Growth Chapter

Singapore, 21st April 2021 – Cityneon Holdings (“Cityneon”, the “Company”/collectively with its subsidiaries, the “Group”) raised S$235 million in the most recent round of

Digitally transforming Southeast Asia’s automotive sector with AI and Technology

2020 was a watershed year for Southeast Asia’s automotive sales. During the pandemic, more people considered buying personal vehicles as a safer option to

ImmunoScape Raises $14M To Advance Deep Immunomics Platform for High-Dimensional Immune Profiling and Drug Discovery

SINGAPORE and SAN DIEGO – April 14, 2021 – ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the

AvePoint Launches EduTech To Improve Higher Education Technology

SINGAPORE, Feb. 28, 2021 – AvePoint, Inc., one of the largest Microsoft 365 data management solutions providers, announced today the global launch of AvePoint

Enhancing the development of the ASEAN markets and accelerating global market expansion for Chinese biopharma companies

Take a deep dive into the ASEAN biopharmaceutical landscape

Moderna Confirms Supply Agreement with the Ministry of Health to Supply Singapore with mRNA Vaccine Against COVID-19 (mRNA-1273)

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,

Singapore-based EDBI named as Pico investor and strategic partner

NEW YORK, NY – November 13, 2019 – Pico, a leading provider of technology-as-a-service for the financial markets community globally, today announced that EDBI,

Startup SG Equity Scheme (Fund-of-funds)

The Startup SG Equity (SSG-E) scheme aims to stimulate private sector investments into innovative and commercially viable Singapore-based technology startups with global market potential.